Rhumbline Advisers Ars Pharmaceuticals, Inc. Comm Transaction History
Rhumbline Advisers
- $121 Billion
- Q3 2025
A detailed history of Rhumbline Advisers transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Rhumbline Advisers holds 81,204 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,204
Previous 81,261
0.07%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions